cimetidine , the first of a new class of pharmacologic agents that dramatically inhibit basal gastric acid secretion , is achieving widespread use for the treatment of such acid peptic disorders as duodenal ulcers , gastritis , and reflux esophagitis .
C0008783
cimetidine
C0014869
reflux esophagitis